What's actually happening inside a cresty horse — and why six years of management hasn't softened it
Caroline and Onyx, her 12-year-old Welsh cob mare. Aiken, South Carolina.
My mare Onyx is twelve years old, a Welsh cob, and she has been "easy keeper" since the day I bought her at four. I have done everything the books told me to do. Dry lot. Soaked hay. Slow feeder. Muzzle on the rare days she goes out on grass. Twelve hours a day of movement when my back will allow it. And still — six years in — her crest doesn't go away.
If you own a horse like this, you know the part nobody puts in the books. The part where the vet says "her insulin is still elevated" and the farrier says "watch those soles, she's standing a little flat," and you look at the cresty pad over her topline and you think: what is that, actually? What is it made of? Why won't it go?
This advertorial is the article I wish someone had handed me five years ago. I'm not a veterinarian. I'm an owner who got tired of platitudes and started reading the journals my vet kept citing. What follows is what I learned, written for the person I was in 2020 — someone managing hard, doing it right, and watching the cresty neck stay.
The crest isn't ordinary fat. It's endocrine tissue.
Adipose — fat — is not one thing. The fat over a horse's ribs and the fat that sits along the crest of the neck are different cell populations, with different gene expression and different jobs. The crest pad is enriched in what researchers call regional adipose — visceral-like tissue that does not exist primarily to store energy.
It exists to talk. It secretes hormones (leptin, adiponectin, resistin), inflammatory signals (TNF-α, IL-6), and it modulates how the rest of the body responds to insulin. The crest is part of the endocrine system.
Which is why the standard advice — feed less, exercise more — only goes so far. You're treating the storage problem. You're not treating the signaling problem.
Frank, N. (2010). Equine Metabolic Syndrome. ACVIM Consensus Statement.
Insulin dysregulation is the root, not the crest.
The 2010 ACVIM consensus on Equine Metabolic Syndrome made one thing clear: insulin dysregulation is the central feature of the disease, not obesity. You can have a thin EMS horse. You can have a fat horse that's metabolically fine. The crest tracks insulin — not weight.
When insulin stays elevated, three things happen at once. Adipose tissue resists clearing glucose. The liver keeps making sugar it doesn't need to make. And the small vessels in the laminae of the hoof lose their ability to relax — the precursor to laminitis.
So the question stops being "how do I get the crest off." The question becomes: how do I lower the insulin signal driving the crest in the first place?
Fitzgerald, D. M. et al. (2019). Cresty neck score is an independent predictor of insulin dysregulation. PLoS ONE 14(7): e0220203.
A flavonoid blend that targets the insulin signal directly.
Every milligram disclosed on the label. $1.05/day on subscription. 60-day promise.
See MetaSupportHow a cresty neck actually forms (it isn't overnight)
The crest isn't the disease. Laminitis is.
This is the part that scared me into reading the literature. The crest, on its own, is a cosmetic problem. The crest as a biomarker is something else entirely.
Morgan et al. (2016) showed that in horses with endocrinopathic laminitis, acetylcholine-induced vessel relaxation in the laminar arteries drops from 323% to 90.8%. The vessels stop being able to open properly. The hoof loses circulation. Tissue dies.
This is not a slow, dignified decline. It is the most common reason easy-keeper horses are euthanized before twenty.
Four flavonoids. Four mechanisms. Every milligram on the label.
MetaSupport is not a "metabolic blend." It's four named flavonoid molecules at clinical doses, each targeting a different part of the insulin–inflammation–vascular cascade.
Targets: The insulin signal itself. Activates the AKT/GSK3β/FOXO1 pathway — the same pathway insulin uses to tell cells to take up glucose. Also inhibits intestinal α-glucosidase, slowing the post-meal sugar spike.
Yan, Y. et al. (2020). Mechanisms of chlorogenic acid in insulin sensitivity. Phytomedicine.
Targets: Inflammation and fat metabolism. Activates the phospholipase C–CaMKK–AMPK pathway — the same cascade metformin works through. Suppresses NF-κB and reduces serum TNF-α, IL-6, and IL-1β.
Hou, X. et al. (2021). DHM activates AMPK signaling. Biomedicine & Pharmacotherapy.
Targets: Vascular function and mast-cell inflammation. The Rutgers equine study (2016) showed quercetin-supplemented Standardbred mares took longer to fatigue and recovered faster. Inhibits the mast-cell histamine release implicated in laminar inflammation.
Ferraro, S. M. et al. (2016). Quercetin in equine inflammation. J Equine Vet Sci.
Targets: The hindgut foundation. Insulin dysregulation isn't only metabolic — it's microbial. Yeast culture stabilizes hindgut pH, supports fiber fermentation, and provides the postbiotic substrate flavonoids need to reach systemic circulation.
Kentucky Equine Research. Hindgut yeast culture & insulin sensitivity reviews.
What 12 weeks on MetaSupport actually looks like
- Hindgut response: firmer manure, less gas, better fiber utilization within 7–10 days.
- Coat: early shine returns from improved absorption.
- What you won't see yet: crest. Tissue takes longer than digestion.
- Insulin trend: retest at week 6 — most owners see meaningful drops in fasting insulin.
- Crest texture: softens before it shrinks. The pad starts to "give" under your hand.
- Energy & recovery: easier to work, quicker to cool out.
- Cresty Neck Score: measurable drop — often a half to a full point on the 0–5 scale.
- Topline: redistributes. Less fat pad, more muscle behind the saddle.
- Stability: the change holds, not a rebound.